Samar Kerkeni, Hubert Marotte, Pierre Miossec. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, Murine-DerivedAntirheumatic Agents/administration & dosageArthritis, Rheumatoid/complicationsArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyAutoantibodies/bloodAutoantibodies/drug effectsAutoantibodies/immunologyAzathioprine/administration & dosageB-Lymphocytes/drug effectsB-Lymphocytes/immunologyDown-Regulation/drug effectsDown-Regulation/immunologyDrug Administration ScheduleDrug Therapy, CombinationFemaleHumansImmunosuppression/methodsImmunosuppressive Agents/administration & dosageMiddle AgedMyasthenia Gravis/complicationsMyasthenia Gravis/drug therapyMyasthenia Gravis/immunologyRituximabSteroids/adverse effectsTime FactorsTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntirheumatic AgentsAutoantibodiesImmunosuppressive AgentsSteroidsRituximabAzathioprine
Year: 2008 PMID: 18816604 DOI: 10.1002/mus.21047
Source DB: PubMed Journal: Muscle Nerve ISSN: 0148-639X Impact factor: 3.217